OTTAWA, May 15, 2017 /CNW/ -
Issue
Health Canada is advising Canadians that the unauthorized health products "Black Mamba 2 Premium" and "ExtenZe" are labelled to contain drugs that may pose serious health risks (DHEA, pregnenolone, and yohimbe/yohimbine). Health Canada seized the products, which are promoted for sexual enhancement, from Yonge and John Medical Pharmacy at 7670 Yonge Street in Thornhill, ON.
Who is affected
- Consumers who have bought or used any of these products.
Affected products
- Black Mamba 2 Premium (yohimbe)
- ExtenZe (DHEA, pregnenolone, and yohimbe bark extract)
What consumers should do
- Stop using these products. Consult with your health care professional if you have used any of these products and have health concerns.
- Read product labels to verify that health products have been authorized for sale by Health Canada. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM). You can also check whether products have been authorized for sale by searching Health Canada's Drug Product Database and Licensed Natural Health Product Database.
- Report adverse events to health products to Health Canada by calling toll-free at 1‑866‑234‑2345, or by reporting online, by mail or by fax.
- Report complaints about health products to Health Canada by calling toll-free at 1‑800‑267‑9675, or complete an online complaint form.
Background
DHEA is a controlled drug that can cause higher than normal levels of female and male hormones in the body and could increase the risk of prostate, breast, ovarian, and other hormone-sensitive cancers. Potential side effects include serious cardiovascular disease, as well as changes in fertility and sperm production. DHEA should be avoided by individuals with a history of abnormal heart rhythms, blood clotting disorders, liver disease and those who are pregnant or breast-feeding.
Pregnenolone is a prescription drug that can cause higher than normal levels of female and male hormones in the body and could increase the risk of prostate, breast, ovarian, and other hormone-sensitive cancers. Pregnenolone should not be used by women who are pregnant or breast-feeding, and should be avoided by individuals who suffer from epileptic seizures or who are taking anti-seizure medications.
Yohimbine is a prescription drug and should be used only under the supervision of a health care professional. Yohimbine is derived from yohimbe, a bark extract. The use of yohimbine or yohimbe may result in serious adverse reactions, particularly in people with high blood pressure, or heart, kidney or liver disease. Side effects include increased blood pressure and heart rate, anxiety, dizziness, tremors, headache, nausea and sleep disorders. It should not be used by children, or pregnant or nursing women.
What Health Canada is doing
Health Canada seized the products from the retail location. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians.
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.
Également disponible en français
SOURCE Health Canada
Media Enquiries: Health Canada, (613) 957-2983; Public Enquiries: (613) 957-2991, 1-866 225-0709
Share this article